GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (FRA:1TZ) » Definitions » Days Sales Outstanding

InfuSystems Holdings (FRA:1TZ) Days Sales Outstanding : 57.46 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is InfuSystems Holdings Days Sales Outstanding?

InfuSystems Holdings's average Accounts Receivable for the three months ended in Dec. 2024 was €20.4 Mil. InfuSystems Holdings's Revenue for the three months ended in Dec. 2024 was €32.3 Mil. Hence, InfuSystems Holdings's Days Sales Outstanding for the three months ended in Dec. 2024 was 57.46.

The historical rank and industry rank for InfuSystems Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:1TZ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.8   Med: 54.58   Max: 62.66
Current: 57.17

During the past 13 years, InfuSystems Holdings's highest Days Sales Outstanding was 62.66. The lowest was 48.80. And the median was 54.58.

FRA:1TZ's Days Sales Outstanding is ranked better than
60.81% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: 65.99 vs FRA:1TZ: 57.17

InfuSystems Holdings's Days Sales Outstanding increased from Dec. 2023 (57.02) to Dec. 2024 (57.46).


InfuSystems Holdings Days Sales Outstanding Historical Data

The historical data trend for InfuSystems Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Days Sales Outstanding Chart

InfuSystems Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.40 51.83 51.99 53.97 54.39

InfuSystems Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.02 57.48 56.42 57.81 57.46

Competitive Comparison of InfuSystems Holdings's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Days Sales Outstanding falls into.


;
;

InfuSystems Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

InfuSystems Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (18.184 + 20.203) / 2 ) / 128.792*365
=19.1935 / 128.792*365
=54.39

InfuSystems Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (20.508 + 20.203) / 2 ) / 32.325*365 / 4
=20.3555 / 32.325*365 / 4
=57.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InfuSystems Holdings  (FRA:1TZ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


InfuSystems Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

InfuSystems Holdings Headlines

No Headlines